THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Rosemary Zuna to Uterine Cervical Neoplasms

This is a "connection" page, showing publications Rosemary Zuna has written about Uterine Cervical Neoplasms.
Connection Strength

7.227
  1. Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis. Cancer Cytopathol. 2018 11; 126(11):950-958.
    View in: PubMed
    Score: 0.512
  2. Adenocarcinoma of the cervix involving the fallopian tube mucosa: report of a case. Diagn Pathol. 2016 Aug 17; 11(1):77.
    View in: PubMed
    Score: 0.440
  3. Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer. Cancer Cytopathol. 2014 Sep; 122(9):694-701.
    View in: PubMed
    Score: 0.377
  4. A fusion-based approach for uterine cervical cancer histology image classification. Comput Med Imaging Graph. 2013 Oct-Dec; 37(7-8):475-87.
    View in: PubMed
    Score: 0.358
  5. Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int J Cancer. 2009 Dec 01; 125(11):2609-13.
    View in: PubMed
    Score: 0.276
  6. Distribution of HPV genotypes in 282 women with cervical lesions: evidence for three categories of intraepithelial lesions based on morphology and HPV type. Mod Pathol. 2007 Feb; 20(2):167-74.
    View in: PubMed
    Score: 0.225
  7. Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion. Cancer. 2006 Oct 25; 108(5):288-97.
    View in: PubMed
    Score: 0.223
  8. Determinants of human papillomavirus-negative, low-grade squamous intraepithelial lesions in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions triage study (ALTS). Cancer. 2005 Oct 25; 105(5):253-62.
    View in: PubMed
    Score: 0.208
  9. Comparison of human papillomavirus genotypes in high-grade squamous intraepithelial lesions and invasive cervical carcinoma: evidence for differences in biologic potential of precursor lesions. Mod Pathol. 2004 Nov; 17(11):1314-22.
    View in: PubMed
    Score: 0.194
  10. Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype. J Clin Oncol. 2023 02 10; 41(5):1059-1068.
    View in: PubMed
    Score: 0.170
  11. Cervical smear interpretations in women with a histologic diagnosis of severe dysplasia: factors associated with discrepant interpretations. Cancer. 2002 Aug 25; 96(4):218-24.
    View in: PubMed
    Score: 0.167
  12. Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management. J Natl Cancer Inst. 2022 06 13; 114(6):845-853.
    View in: PubMed
    Score: 0.165
  13. HPV DNA testing of the residual sample of liquid-based Pap test: utility as a quality assurance monitor. Mod Pathol. 2001 Mar; 14(3):147-51.
    View in: PubMed
    Score: 0.151
  14. Accuracy and Efficiency of Deep-Learning-Based Automation of Dual Stain Cytology in Cervical Cancer Screening. J Natl Cancer Inst. 2021 01 04; 113(1):72-79.
    View in: PubMed
    Score: 0.149
  15. Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral-host interaction with implications for disease intervention. Int J Cancer. 2020 11 15; 147(10):2677-2686.
    View in: PubMed
    Score: 0.143
  16. A Systematic Review of Tests for Postcolposcopy and Posttreatment Surveillance. J Low Genit Tract Dis. 2020 Apr; 24(2):148-156.
    View in: PubMed
    Score: 0.141
  17. Reporting and Assessing the Quality of Diagnostic Accuracy Studies for Cervical Cancer Screening and Management. J Low Genit Tract Dis. 2020 Apr; 24(2):157-166.
    View in: PubMed
    Score: 0.141
  18. Identification of HPV genotypes causing cervical precancer using tissue-based genotyping. Int J Cancer. 2020 05 15; 146(10):2836-2844.
    View in: PubMed
    Score: 0.140
  19. Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes. J Infect Dis. 2019 10 08; 220(10):1609-1619.
    View in: PubMed
    Score: 0.137
  20. Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women. Papillomavirus Res. 2019 06; 7:67-74.
    View in: PubMed
    Score: 0.130
  21. A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers. Am J Obstet Gynecol. 2018 06; 218(6):604.e1-604.e8.
    View in: PubMed
    Score: 0.122
  22. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology. Obstet Gynecol. 2017 12; 130(6):1218-1225.
    View in: PubMed
    Score: 0.120
  23. HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis. Cell. 2017 Sep 07; 170(6):1164-1174.e6.
    View in: PubMed
    Score: 0.118
  24. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer. Int J Cancer. 2017 08 15; 141(4):701-710.
    View in: PubMed
    Score: 0.116
  25. A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 05; 145(2):291-297.
    View in: PubMed
    Score: 0.114
  26. Proof-of-principle study of a novel cervical screening and triage strategy: Computer-analyzed cytology to decide which HPV-positive women are likely to have =CIN2. Int J Cancer. 2017 Feb 01; 140(3):718-725.
    View in: PubMed
    Score: 0.111
  27. Utility of the cervical cytologic smear in assessing endocervical involvement by endometrial carcinoma. Acta Cytol. 1996 Sep-Oct; 40(5):878-84.
    View in: PubMed
    Score: 0.110
  28. Comparison of Colposcopic Impression Based on Live Colposcopy and Evaluation of Static Digital Images. J Low Genit Tract Dis. 2016 Apr; 20(2):154-61.
    View in: PubMed
    Score: 0.107
  29. Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer. Carcinogenesis. 2016 Feb; 37(2):188-196.
    View in: PubMed
    Score: 0.105
  30. Nuclei-Based Features for Uterine Cervical Cancer Histology Image Analysis With Fusion-Based Classification. IEEE J Biomed Health Inform. 2016 11; 20(6):1595-1607.
    View in: PubMed
    Score: 0.104
  31. Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling. Proc Natl Acad Sci U S A. 2015 Jun 23; 112(25):E3255-64.
    View in: PubMed
    Score: 0.101
  32. Multiple biopsies and detection of cervical cancer precursors at colposcopy. J Clin Oncol. 2015 Jan 01; 33(1):83-9.
    View in: PubMed
    Score: 0.098
  33. Evaluation of a multiplex panel of immune-related markers in cervical secretions: a methodologic study. Int J Cancer. 2014 Jan 15; 134(2):411-25.
    View in: PubMed
    Score: 0.089
  34. Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results. Gynecol Oncol. 2013 Sep; 130(3):595-600.
    View in: PubMed
    Score: 0.088
  35. The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecol Oncol. 2013 Feb; 128(2):265-70.
    View in: PubMed
    Score: 0.085
  36. Tubal ligation frequency in Oklahoma women with cervical cancer. Gynecol Oncol. 2012 Nov; 127(2):278-82.
    View in: PubMed
    Score: 0.083
  37. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012 Aug 01; 18(15):4154-62.
    View in: PubMed
    Score: 0.082
  38. Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management. Int J Cancer. 2013 Jan 01; 132(1):148-54.
    View in: PubMed
    Score: 0.082
  39. Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16. Int J Cancer. 2012 Sep 15; 131(6):E946-53.
    View in: PubMed
    Score: 0.081
  40. Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3. PLoS One. 2012; 7(1):e29051.
    View in: PubMed
    Score: 0.080
  41. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Oncogene. 2012 May 31; 31(22):2725-37.
    View in: PubMed
    Score: 0.079
  42. Peritoneal washing cytology in cervical carcinoma. Analysis of 109 patients. Acta Cytol. 1990 Sep-Oct; 34(5):645-51.
    View in: PubMed
    Score: 0.073
  43. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer. 2009 Nov 01; 125(9):2151-8.
    View in: PubMed
    Score: 0.069
  44. Accuracy of cervical specimens obtained for biomarker studies in women with CIN3. Gynecol Oncol. 2009 Dec; 115(3):493-6.
    View in: PubMed
    Score: 0.068
  45. Laser capture microdissection of cervical human papillomavirus infections: copy number of the virus in cancerous and normal tissue and heterogeneous DNA methylation. Virology. 2009 Aug 01; 390(2):261-7.
    View in: PubMed
    Score: 0.067
  46. Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma. Int J Cancer. 2009 Feb 15; 124(4):964-9.
    View in: PubMed
    Score: 0.065
  47. Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):113-20.
    View in: PubMed
    Score: 0.065
  48. Towards improved biomarker studies of cervical neoplasia: effects of precolposcopic procedures on gene expression patterns. Diagn Mol Pathol. 2005 Jun; 14(2):59-64.
    View in: PubMed
    Score: 0.051
  49. Association of condylomas with intraepithelial and microinvasive cervical neoplasia: histopathology of conization and hysterectomy specimens. Int J Gynecol Pathol. 1984; 2(4):364-72.
    View in: PubMed
    Score: 0.046
  50. Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance. Nat Commun. 2020 02 14; 11(1):886.
    View in: PubMed
    Score: 0.035
  51. Development of the TypeSeq Assay for Detection of 51 Human Papillomavirus Genotypes by Next-Generation Sequencing. J Clin Microbiol. 2019 05; 57(5).
    View in: PubMed
    Score: 0.033
  52. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients. J Natl Cancer Inst. 1996 Jul 17; 88(14):980-7.
    View in: PubMed
    Score: 0.027
  53. Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods. BMC Infect Dis. 2015 Nov 25; 15:544.
    View in: PubMed
    Score: 0.026
  54. Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. J Clin Virol. 2014 Aug; 60(4):414-7.
    View in: PubMed
    Score: 0.023
  55. Human papillomavirus 16 E5 induces bi-nucleated cell formation by cell-cell fusion. Virology. 2009 Feb 05; 384(1):125-34.
    View in: PubMed
    Score: 0.016
  56. Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. Cancer Res. 2008 Mar 15; 68(6):1636-46.
    View in: PubMed
    Score: 0.015
  57. A LEEP cervical conization is rarely indicated for a two-step discrepancy. J Low Genit Tract Dis. 2007 Jul; 11(3):134-7.
    View in: PubMed
    Score: 0.015
  58. The Pap smear revisited. Controversies and recent developments. Postgrad Med. 1984 Nov 01; 76(6):36-40, 42-3, 46.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES